Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

929.95

1.10 (0.12%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences’ arm gets nod to market Mirabegron Extended-Release Tablets

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences gets USFDA’s final nod to market Sildenafil for oral suspension

>>

USFDA completes inspection at Zydus Lifesciences’ arm’s unit with 2 observation

>>

Zydus Lifesciences informs about loss of share certificate

>>

Zydus Lifesciences moves up on launching Lenalidomide Capsules in US

>>

Zydus Lifesciences launches Lenalidomide Capsules in US

>>

Zydus Lifesciences’ arm receives USFDA’s tentative approval for Sugammadex Injection

>>

Zydus Lifesciences informs about loss of share certificate

>>

Zydus Lifesciences informs about investors meet

<< < 58 59 60 ...168 > >>